mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |